Tulathromycin

Tulathromycin
Systematic (IUPAC) name
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-Ο-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyrano-syl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan-15-one
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
217500-96-4
QJ01FA94
ChemSpider 24583287 Yes
UNII Q839I13422 Yes
KEGG D06258 Yes
Chemical data
Formula C41H79N3O12
806.08 g/mol
 Yes (what is this?)  (verify)

Tulathromycin is a macrolide antibiotic used to treat bovine respiratory disease (BRD) in cattle and swine respiratory disease in pigs. It is marketed by Pfizer Inc. under the tradename Draxxin.

It is supplied as a solution for injection containing 100 mg of the drug. [1]

References

  1. Draxxin at draxxin.com

External links